Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?

Refers to: Viral kinetics for individualized treatment durations, Journal of Hepatology, Volume 54, Issue 4, April 2011, Pages 836-837

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2011-04, Vol.54 (4), p.835-836
Main Authors: Lagging, Martin, Alsiö, Åsa, Hellstrand, Kristoffer, Norkrans, Gunnar
Format: Article
Language:English
Subjects:
Antiviral Agents - administration & dosage
Antiviral Agents - economics
Cost-Benefit Analysis
Drug Administration Schedule
Gastroenterology and Hepatology
Genotype
Hepacivirus - genetics
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - economics
Hepatitis C, Chronic - virology
Humans
Interferon Type I - administration & dosage
Interferon Type I - economics
Microbiology in the medical area
Mikrobiologi inom det medicinska området
Recombinant Proteins
RNA, Viral - blood
Time Factors
Viral Load
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Refers to: Viral kinetics for individualized treatment durations, Journal of Hepatology, Volume 54, Issue 4, April 2011, Pages 836-837
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2010.09.038